The European Medicines Agency has issued final guidance outlining the procedure that notified bodies designated to review in vitro diagnostics (IVDs) must follow when seeking a scientific opinion on the suitability of a companion diagnostic (CDx) with the concerned medicinal product.
The guideline is expected to further support the development of CDxs or biomarkers that are a critical tool for furthering...